355 related articles for article (PubMed ID: 25618015)
1. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Soliman AM
Eur J Med Chem; 2016 Jul; 117():8-18. PubMed ID: 27085944
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MG
Arzneimittelforschung; 2012 Jan; 62(1):46-52. PubMed ID: 22331763
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
6. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase.
Debbabi KF; Al-Harbi SA; Al-Saidi HM; Aljuhani EH; Abd El-Gilil SM; Bashandy MS
J Enzyme Inhib Med Chem; 2016; 31(sup4):7-19. PubMed ID: 27557134
[TBL] [Abstract][Full Text] [Related]
7. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MGM
Bioorg Med Chem Lett; 2018 May; 28(9):1464-1470. PubMed ID: 29628325
[TBL] [Abstract][Full Text] [Related]
8. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM
Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843
[TBL] [Abstract][Full Text] [Related]
11. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
Ghorab MM; Shaaban MA; Refaat HM; Heiba HI; Ibrahim SS
Eur J Med Chem; 2012 Jul; 53():403-7. PubMed ID: 22583778
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
13. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)-benzenesulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MG
Acta Pharm; 2011 Dec; 61(4):415-25. PubMed ID: 22202200
[TBL] [Abstract][Full Text] [Related]
15. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Bayomi AA
Arzneimittelforschung; 2011; 61(12):719-26. PubMed ID: 22282960
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
Halawa AH; Elgammal WE; Hassan SM; Hassan AH; Nassar HS; Ebrahim HY; Mehany ABM; El-Agrody AM
Bioorg Chem; 2020 May; 98():103725. PubMed ID: 32199303
[TBL] [Abstract][Full Text] [Related]
17. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
Ghorab MM; Alsaid MS; Nissan YM; Ashour AE; Al-Mishari AA; Kumar A; Ahmed SF
Chem Pharm Bull (Tokyo); 2016; 64(12):1747-1754. PubMed ID: 27904083
[TBL] [Abstract][Full Text] [Related]
18. Novel pyrazole derivatives as anticancer and radiosensitizing agents.
Aly HM; El-Gazzar MG
Arzneimittelforschung; 2012 Mar; 62(3):105-12. PubMed ID: 22407898
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pro-apoptotic effects of new sulfonamide derivatives via activating p38/ERK phosphorylation in cancer cells.
Cumaoglu A; Dayan S; Agkaya AO; Ozkul Z; Ozpozan NK
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):413-9. PubMed ID: 25198886
[TBL] [Abstract][Full Text] [Related]
20. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
